MedPath

吉林省罗邦药业有限公司

Ownership
-
Established
2004-07-12
Employees
-
Market Cap
-
Website
www.jllbyy.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

56

NMPA:56

Drug Approvals

生脉饮

Approval Number
国药准字Z22023034
Approval Date
May 11, 2021
NMPA

Cefalexin Tablets

Product Name
头孢氨苄片
Approval Number
国药准字H22023698
Approval Date
Jun 12, 2020
NMPA

Troxerutin Tablets

Product Name
曲克芦丁片
Approval Number
国药准字H22025543
Approval Date
Jun 2, 2020
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H22023456
Approval Date
Jun 2, 2020
NMPA

Rifampicin Tablets

Product Name
利福平片
Approval Number
国药准字H22023600
Approval Date
Jun 2, 2020
NMPA

Vitamin B1 Pills

Product Name
维生素B1丸
Approval Number
国药准字H22023433
Approval Date
Jun 2, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H22023621
Approval Date
Jun 2, 2020
NMPA

Kitasamycin Tablets

Product Name
吉他霉素片
Approval Number
国药准字H22023431
Approval Date
Jun 2, 2020
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H22023437
Approval Date
Jun 2, 2020
NMPA

Vitamin B2 Tablets

Product Name
维生素B2片
Approval Number
国药准字H22023450
Approval Date
Jun 2, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.